Two rodent models that spontaneously develop type 1 diabetes, the NOD (non-obese diabetic) mouse and the BB (BioBreeding) rat, have allowed ... is extremely broad; symptoms occur at any time ...

Cloaking is a key goal for cell-replacement therapies being tested for conditions ranging from type 2 diabetes ... brains of rats treated with a neurotoxin whose effects mimic the symptoms of ...

MIRA's Ketamir-2 shows promise in treating diabetic neuropathy, with a Phase 2a trial expected by late 2025 and human data in ...